Back Home Search

Non-Production - Adjuvant

    • Protocols

    • EAY191N4

      OPEN TO ACCRUAL

      Ph2 Randomized Selumetinib, Olaparib or Selumetinib in Patients w/Ovarian and Endometrial Cancer